Showing 25791 - 25800 of 27839 for "Pharmaceuticals and life sciences" with applied filters
30 March 2016 by Cesar Arbe Saldaña
Cesar Arbe Saldaña of Arbe Abogados assesses the M&A regulatory framework in Peru
30 March 2016 by Swee Gim Cheah and Lyra Miragrace Flores
Swee Gim Cheah and Lyra Miragrace Flores of Kelvin Chia Yangon provide an update on the latest M&A trends in Myanmar
29 March 2016 by Fernando de las Cuevas and Ignacio de la Fuente
Fernando de las Cuevas and Ignacio de la Fuente of Gómez-Acebo & Pombo assess the M&A regulatory framework in Spain
29 March 2016 by Alexander Vogel, Andrea Sieber and Samuel Ljubicic
Alexander Vogel, Andrea Sieber and Samuel Ljubicic of Meyerlustenberger Lachenal assess the M&A regulatory framework in Switzerland
29 March 2016 by Lorcan Tiernan and Adrian Benson
Lorcan Tiernan and Adrian Benson of Dillon Eustace assess the M&A regulatory framework in Ireland
29 March 2016 by Claudine Maeijer and Rob Faasen
Claudine Maeijer and Rob Faasen of Eversheds assess the latest M&A trends and developments in the Netherlands
29 March 2016 by Miguel Spínola and Josina Correia
Miguel Spínola and Josina Correia of PLMJ assess the M&A regulatory framework in Mozambique
29 March 2016 by Steven Brown and Paul Day
Steven Brown and Paul Day of ASAR - Al Ruwayeh & Partners assess the M&A regulatory framework in Bahrain
29 March 2016 by André Figueiredo and Duarte Schmidt Lino
André Figueiredo and Duarte Schmidt Lino of PLMJ assess the M&A regulatory framework in Portugal
29 March 2016 by Ruben Brigolas and Sónia Martins Reis
Ruben Brigolas and Sónia Martins Reis of PLMJ assess the M&A regulatory framework in Angola